Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03450018
Title A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX (SLC-0111-17-01)
Recruitment Suspended
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors British Columbia Cancer Agency
Indications

pancreatic ductal adenocarcinoma

Therapies

Gemcitabine + SLC-0111

Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.